Format: Grand Rounds

7-12 of 12 Activities
Title
Availability
Format
Credits
Launch Date
Buttons
Live
Grand Rounds
1
12/16/2024 at 12:00 PM EST

All Hands on Deck – Utilizing JAK Inhibitors in Myelofibrosis Care: Evidence, Timing, and Strategic Approaches

In this CE Concepts Grand Rounds series, expert faculty will discuss assessing patients for MF therapy, integrating current and emerging data on JAKis in MF, developing individualized strategies to reduce treatment toxicity and enhance treatment adherence, and evaluating health disparities in MF. The faculty will also provide insight through case examples. 

1
12/16/2024 at 12:00 PM EST

Aaron T. Gerds, MD, MS

Aaron T. Gerds, MD, MS

Live
Grand Rounds
1
12/20/2024 at 12:00 PM EST

Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer

In this Grand Rounds activity, a breast cancer expert will guide participants through a discussion of criteria to select patients to receive ADCs, adverse event (AE) management, and strategies to foster equitable care of patients with metastatic breast cancer (mBC).

1
12/20/2024 at 12:00 PM EST

Yara Abdou, MD

Yara Abdou, MD

Live
Grand Rounds
1
11/20/2024 at 7:00 PM EST

Tailoring Patient Care Using Novel Agents in Metastatic Urothelial Carcinoma: Strategies for the Interprofessional Team

Join our expert faculty for this 60-minute activity designed to help clinicians stay abreast of emerging trial data and evolving treatment guidelines, as well as effectively manage agent-specific AEs, to optimize care for their patients with mUC.

1
11/20/2024 at 7:00 PM EST

Petros Grivas, MD, PhD

Petros Grivas, MD, PhD

Live
Grand Rounds
1
12/05/2024 at 12:00 PM EST

Tailoring Patient Care Using Novel Agents in Metastatic Urothelial Carcinoma: Strategies for the Interprofessional Team

Join our expert faculty for this 60-minute activity designed to help clinicians stay abreast of emerging trial data and evolving treatment guidelines, as well as effectively manage agent-specific AEs, to optimize care for their patients with mUC.

1
12/05/2024 at 12:00 PM EST

Robert Dreicer, MD, MS, MACP, FASCO

Robert Dreicer, MD, MS, MACP, FASCO

Live
Grand Rounds
1
11/15/2024 at 12:00 PM EST

Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer

In this Grand Rounds activity, a breast cancer expert will guide participants through a discussion of criteria to select patients to receive ADCs, adverse event (AE) management, and strategies to foster equitable care of patients with metastatic breast cancer (mBC).

1
11/15/2024 at 12:00 PM EST

Sara Tolaney, MD, MPH

Sara Tolaney, MD, MPH

On-Demand
Grand Rounds
1
07/02/2024

Advancements and Applications of Antibody Drug Conjugates in HER2-Negative Breast Cancer

In this Grand Rounds activity, a breast cancer expert will guide participants through a discussion of criteria to select patients to receive ADCs, adverse event (AE) management, and strategies to foster equitable care of patients with metastatic breast cancer (mBC).

1
07/02/2024

Sara Tolaney, MD, MPH

Sara Tolaney, MD, MPH